Tanvi Foods (540332)
Fast GrowerScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹140 |
| Market Cap | ₹164.99 Cr |
| P/E Ratio | 123.76 |
| ROCE | 2.88% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 282.35% |
| Debt/Equity | — |
| Sales Growth | 9.33% |
| 52-Week Range | ₹54.5 — ₹140 |
| Sector | Food Products |
Strengths
- Piotroski F-Score of 7/9 reflects sound recent financial health across profitability, leverage and operating efficiency.
- Profit growth of 282.35% and PEG of 0.85 show strong earnings momentum, if the low-base growth can be repeated.
- Latest quarter sales of ₹48 Cr show the business is generating steady revenue; sales growth is positive at 9.33%.
- Small market cap of ₹165 Cr leaves room for a genuine small-cap compounder if management executes well.
Concerns
- P/E of 123.76 is extremely rich; even a PEG below 1 depends on 282% profit growth that may be a low-base artifact.
- Latest quarter net profit of ₹1 Cr on ₹48 Cr sales means only ~2% net margin, leaving little room for setbacks.
- ROCE of 2.88% signals weak capital efficiency and no obvious competitive moat.
- Zero dividend and missing book value, ROE, and promoter holding data reduce the ability to estimate intrinsic value or protect downside.
AI Analysis
Tanvi Foods trades at ₹140, capitalising the company at ₹165 crore. A price-to-earnings ratio of 123.76 is far from anything Ben Graham would call a bargain. The 282% profit growth looks exciting at first, but it rests on a very low base: the latest quarter generated only ₹1 crore net profit on ₹48 crore of sales, a margin of roughly 2%. Sales growth is just 9.33%, so this is not a high-demand compounding machine. ROCE of 2.88% tells me the company is not earning an attractive return on the capital employed. With no dividend, the shareholder is wholly dependent on the share price continuing to rise, and at the top of a 52-week range of ₹54.50 to ₹140, Mr. Market is already euphoric. The Piotroski F-score of 7/9 is a point in favour, suggesting that recent financial health is reasonable. A PEG of 0.85 would be comforting if the 282% profit growth were sustainable, but I cannot assume that from a modest sales growth rate. There are too many missing facts: no book value, no ROE, no promoter holding. Graham taught me to favour knowledge over hope. Without these fundamentals, I cannot calculate a margin of safety. This strikes me as a story stock, not a durable enterprise. I would watch whether net margins expand from this thin level; whether sales growth accelerates; and whether the company can improve its return on capital. Until then, the risk/reward is poor at ₹140. I would rather pass and wait for a better price, or better evidence, before committing a rupee.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer